ProQomics is pioneering high-throughput proteoform quantitation through a cutting-edge mass spectrometry platform. Our technology is designed to provide accurate, large-scale quantification of proteoforms and post-translationally modified proteins, empowering researchers and pharmaceutical companies to gain deeper insights into the molecular mechanisms of diseases. By combining multiplexed immuno arrays with high-resolution mass spectrometry, ProQomics enables faster, more detailed protein profiling—critical for drug discovery and biomarker development. Our products include innovative reagents, internal standards, and front-end instruments that streamline proteomics workflows, transforming how proteoforms are analyzed in research and industry.
| Website | https://proqomics.com |
| Employees | 3 (2 on RocketReach) |
| Founded | 2024 |
| Industry | Biotechnology Research |
| Keywords | Mass Spectrometry, Protein Quantification, Protein Characterization, Biomarker Identification, Clinical Proteomics, Drug Discovery, Proteomics Research, Life Science Research, Biotechnology, Omics Technology |
Looking for a particular ProQomics employee's phone or email?
Tamil Anthonymuthu is the Founder and CEO of ProQomics.
2 people are employed at ProQomics.